Cefazolin

+ 23 more variants

• Skin Rash: A mild, itchy red rash or hives (urticaria) may develop. This is often a sign of a mild allergic sensitivity.
• Loss of Appetite (Anorexia): Some patients report a decreased interest in food or a metallic taste in the mouth during treatment.
• Elevated Liver Enzymes: Transient increases in AST, ALT, or alkaline phosphatase may be seen on blood tests, usually without symptoms of liver damage.

• Hematologic Changes: Rare cases of decreased white blood cell counts (leukopenia or neutropenia) or decreased platelets (thrombocytopenia) have been reported. This can increase the risk of infection or bruising.
• Drug Fever: A fever that occurs as a direct reaction to the medication itself, rather than the underlying infection.
• Eosinophilia: An increase in a specific type of white blood cell often associated with allergic reactions.

> Warning: Stop receiving Cefazolin and call your doctor immediately or seek emergency care if you experience any of the following:

1. 1Anaphylaxis (Severe Allergic Reaction): Symptoms include swelling of the face, lips, or throat; difficulty breathing or wheezing; a rapid pulse; and a sharp drop in blood pressure (fainting).
2. 2Clostridioides difficile-Associated Diarrhea (CDAD): This is a severe form of diarrhea caused by a toxin-producing bacterium. Symptoms include watery or bloody stools, severe stomach cramps, and fever. This can occur even weeks after the antibiotic treatment has ended.
3. 3Severe Skin Reactions: Rare but life-threatening conditions like Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). Watch for skin peeling, blistering, or a painful purple/red rash that spreads.
4. 4Neurotoxicity/Seizures: Especially in patients with kidney impairment, high levels of Cefazolin can trigger seizures, confusion, or involuntary muscle twitching (myoclonus).
5. 5Nephrotoxicity: Signs of kidney damage, such as a significant decrease in urine output, swelling in the legs or ankles, or blood in the urine.
6. 6Hepatotoxicity: Signs of liver damage, including yellowing of the skin or eyes (jaundice), dark urine, and severe upper abdominal pain.

Cefazolin is typically used for short-term acute treatment. However, prolonged use (weeks) can lead to:

• Superinfection: The emergence of resistant bacteria or fungi that are not killed by Cefazolin, requiring different treatments.
• Vitamin K Deficiency: In rare cases, long-term use of cephalosporins can interfere with Vitamin K production in the gut, potentially leading to bleeding problems, especially in malnourished patients or those with liver disease.
• Positive Coombs Test: Long-term use can cause a positive result on a Coombs test (a blood test for antibodies), which might complicate blood typing or indicate a rare form of anemia (hemolytic anemia).

No FDA black box warnings currently exist for Cefazolin. However, the FDA requires warnings regarding the risk of hypersensitivity reactions and C. difficile-associated diarrhea on all cephalosporin labels.

Report any unusual symptoms to your healthcare provider promptly. Early detection of side effects often allows for safer management or a transition to an alternative therapy.

Patients receiving prolonged courses of Cefazolin (e.g., for osteomyelitis or endocarditis) require regular monitoring to ensure safety:

• Complete Blood Count (CBC): To check for leukopenia or thrombocytopenia.
• Renal Function Tests: Monitoring serum creatinine and BUN (Blood Urea Nitrogen) is essential, especially in the elderly or those with known kidney disease.
• Liver Function Tests (LFTs): To monitor for transient elevations in liver enzymes.
• Prothrombin Time (PT/INR): In patients at risk for bleeding or those taking anticoagulants like Warfarin.

Cefazolin generally does not interfere with the ability to drive or operate machinery. However, if you experience side effects such as dizziness, confusion, or seizures, you should avoid these activities and contact your doctor immediately.

While Cefazolin does not have a classic 'disulfiram-like' reaction with alcohol (unlike some other cephalosporins like Cefotetan), it is generally advised to avoid alcohol while fighting a serious infection. Alcohol can dehydrate the body and interfere with the immune system's ability to recover.

It is critical to complete the full course of Cefazolin as prescribed by your doctor. Stopping the medication early, even if you feel better, can allow the remaining bacteria to multiply and develop resistance, making the infection much harder to treat in the future.

> Important: Discuss all your medical conditions, especially kidney disease and past drug allergies, with your healthcare provider before starting Cefazolin.

• Probenecid: Probenecid is a medication used for gout that blocks the renal tubular secretion of Cefazolin. Taking these together will result in higher and more prolonged blood levels of Cefazolin. While sometimes used intentionally to boost antibiotic levels, it can also increase the risk of side effects.
• Loop Diuretics (e.g., Furosemide/Lasix): Some studies suggest that high doses of cephalosporins combined with potent diuretics may increase the risk of kidney impairment.

Since Cefazolin is administered by injection, food does not affect its absorption. There are no known interactions with grapefruit, dairy, or high-fat meals. However, maintaining adequate hydration is important while being treated for an infection to support kidney function and drug clearance.

• Vitamin K: Since Cefazolin can lower Vitamin K levels, taking large amounts of Vitamin K supplements might theoretically counteract some effects, though this is rarely a clinical concern unless the patient has a bleeding disorder.
• Probiotics: While many patients take probiotics to prevent antibiotic-associated diarrhea, they should be taken a few hours apart from the Cefazolin dose (if possible) to ensure the antibiotic doesn't simply kill the probiotic bacteria.
• St. John's Wort: There is no known direct interaction, but St. John's Wort can affect many other medications; always inform your doctor.

Cefazolin can interfere with certain laboratory tests, leading to false results:

• Urinary Glucose Tests: It may cause a false-positive reaction for glucose in the urine when using copper reduction tests (like Benedict's solution or Clinitest). It does not affect glucose oxidase-based tests (like Diastix).
• Coombs Test: A false-positive direct Coombs test may occur. This is important for blood banks to know if a patient requires a blood transfusion.
• Creatinine Tests: High concentrations of Cefazolin can interfere with the Jaffe reaction, leading to falsely elevated serum creatinine readings.

For each major interaction, the mechanism usually involves either competitive inhibition of renal excretion (Probenecid) or additive toxic effects on the kidneys (Aminoglycosides). Management strategies involve dose adjustment, increased monitoring, or choosing alternative therapies.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs.

• Renal Insufficiency: Patients with significantly impaired kidney function are at high risk for Cefazolin-induced neurotoxicity (seizures). While not a reason to avoid the drug entirely, it requires strict dose modification.
• History of Gastrointestinal Disease: Particularly colitis. Patients with a history of C. difficile or ulcerative colitis may be at higher risk for severe antibiotic-associated colitis.
• Seizure Disorders: Because Cefazolin can lower the seizure threshold, patients with known epilepsy should be monitored closely.
• Poor Nutritional Status: Patients who are malnourished or have Vitamin K deficiencies are at a higher risk for bleeding complications when taking Cefazolin.

As mentioned, cross-sensitivity is a major concern. If you are allergic to one beta-lactam (like Amoxicillin or Penicillin VK), there is a chance your immune system will recognize Cefazolin as a threat. Always provide a detailed description of your past allergic reactions (e.g., 'I got a small rash' vs. 'I couldn't breathe') to your healthcare provider so they can make an informed decision.

> Important: Your healthcare provider will evaluate your complete medical history and the severity of your infection before prescribing Cefazolin. Always wear a medical alert bracelet if you have a severe drug allergy.

• Risks to Infant: The main concerns for a nursing infant are the potential for a change in bowel habits (diarrhea), the development of oral thrush, or the rare possibility of becoming sensitized to the drug (developing an allergy).
• Risk-Benefit: Most experts agree that the benefits of breastfeeding outweigh the minimal risks of Cefazolin exposure through milk.

Cefazolin is safe and effective for use in children, including infants over one month of age.

• Safety: The safety profile in children is similar to that in adults.
• Premature Infants: Safety in premature infants and neonates under one month of age has not been as extensively documented, though it is frequently used in neonatal intensive care units (NICUs) with adjusted dosing intervals due to immature kidney function.
• Growth Effects: There are no known adverse effects of Cefazolin on bone growth or development in children.

Clinical studies of Cefazolin did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. However:

• Renal Clearance: The most significant concern in the elderly is the natural decline in kidney function. Since Cefazolin is renally excreted, the risk of toxic reactions is higher in patients with impaired renal function.
• Polypharmacy: Elderly patients are more likely to be on other medications (like diuretics or blood thinners) that can interact with Cefazolin.
• Dosing: Doctors usually start at the lower end of the dosing range and monitor kidney function closely.

In patients with a Creatinine Clearance (CrCl) of less than 55 mL/min, the half-life of Cefazolin increases significantly. Dose adjustments are mandatory (see Usage Instructions). For patients on hemodialysis, Cefazolin is dialyzable; roughly 20-50% of the drug is removed during a standard session, requiring a 'top-up' dose afterward.

No dosage adjustment is generally required for patients with liver disease (Child-Pugh Class A, B, or C). However, because these patients may also have underlying coagulopathies (bleeding issues), they should be monitored for any signs of increased bruising or bleeding.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

| Parameter | Value |

|---|---|

| Bioavailability | N/A (Administered IV/IM) |

| Protein Binding | 70% to 85% |

| Half-life | 1.8 to 2.0 hours (Normal Renal Function) |

| Tmax | 1-2 hours (IM); Immediate (IV) |

| Metabolism | Minimal (Hepatic) |

| Excretion | Renal (80-100% unchanged) |

• Molecular Formula: C14H14N8O4S3 (Cefazolin)
• Molecular Weight: 454.5 g/mol
• Solubility: Freely soluble in water; very slightly soluble in alcohol.
• Structure: It contains a beta-lactam ring fused to a six-membered dihydrothiazine ring (the cephem nucleus), with a thiadiazole side chain at the 3-position and a tetrazolylacetamido group at the 7-position.

Cefazolin is a First-Generation Cephalosporin. Related medications in this class include Cephalexin (Keflex) and Cefadroxil (Duricef). While later generations (2nd, 3rd, 4th) offer broader Gram-negative coverage, first-generation agents like Cefazolin remain superior for most susceptible Gram-positive skin and soft tissue infections.